Statins

Effect of statin on MS progression not related to cholesterol reduction

A previously demonstrated effect of simvastatin in delaying progression of an advanced form of multiple sclerosis is not related to its effect on cholesterol levels, a study published in PNAS has shown.…

Half of patients taking statins fail to reach optimal cholesterol levels within two years

Over half of patients started on statin therapy do not achieve optimal therapeutic reduction of their cholesterol within two years, a study published in Heart has found.…

Alternative take on statins, fat and cholesterol is an intriguing read

A Statin Nation: Damaging millions in a brave new post-health world by Malcolm Kendrick.…

Statins reduce risk of major vascular events in all ages, study finds

Statins reduce the risk of vascular events in people of all ages, although there is less evidence of this in people aged over 75 years than in younger patients, researchers have found.…

Increased intensity plus adherence maximises statin benefits

High adherence to intensive lipid-lowering therapy provides the greatest risk reduction for cardiovascular events, a study in JAMA Network Open has shown.…

First-year statin discontinuation and non-adherence common in older adults

A substantial proportion of older people who begin taking statins do not take them as intended, according to an Australian study published in the British Journal of Clinical Pharmacology.…

Recommended ten-year risk thresholds for statin prescriptions are too low, study results suggest

Higher ten-year risk thresholds should be used when recommending statins for the primary prevention of cardiovascular disease, study results have concluded.…

Lack of evidence to support statin use in non-cardiovascular conditions

There is a lack of ‘convincing’ evidence that statins improve outcomes in non-cardiovascular conditions, such as diabetes, a review has shown.…

Study results do not support widespread use of statins in old and very old populations

Statins do not prevent the development of atherosclerotic cardiovascular disease (CVD) in people without diabetes aged 75 years and over, according to a study published in the BMJ.…

Statins: the highs and the lows

Negative press seems to follow statins, the most prescribed drugs in England, despite them revolutionising cardiovascular disease prevention.…